Patents by Inventor Arnold S. Breitbart

Arnold S. Breitbart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6398816
    Abstract: A method for enhancing and/or increasing the efficiency of repair of tissues, primarily bone or cartilage, using genetically engineered cells has been developed. In the preferred embodiment, mesenchymal stem cells are isolated from periosteum tissue, and transfected with the gene encoding a growth factor for the particular cell type to be repaired. For example, for repair of bone, a gene (or genes) encoding bone morphogenic protein is transfected into periosteal cells. The transfected periosteal cells then express the bone morphogenic protein in culture to promote bone repair as a function of the expressed bone morphogenic protein. Cells can be transfected using any appropriate means, including viral vectors, as shown by the example, chemical transfectants, or physico-mechanical methods such as electroporation and direct diffusion of DNA.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: June 4, 2002
    Assignee: North Shore-Long Island Jewish Research Institute
    Inventors: Arnold S. Breitbart, Daniel A. Grande, James M. Mason
  • Patent number: 6077987
    Abstract: A method for enhancing and/or increasing the efficiency of repair of tissues, primarily bone or cartilage, using genetically engineered cells has been developed. In the preferred embodiment, mesenchymal stem cells are isolated from periosteum tissue, and transfected with the gene encoding a growth factor for the particular cell type to be repaired. For example, for repair of bone, a gene (or genes) encoding bone morphogenic protein is transfected into periosteal cells. The transfected periosteal cells then express the bone morphogenic protein in culture to promote bone repair as a function of the expressed bone morphogenic protein. Cells can be transfected using any appropriate means, including viral vectors, as shown by the example, chemical transfectants, or physico-mechanical methods such as electroporation and direct diffusion of DNA.
    Type: Grant
    Filed: September 4, 1997
    Date of Patent: June 20, 2000
    Assignee: North Shore-Long Island Jewish Research Institute
    Inventors: Arnold S. Breitbart, Daniel S. Grande, James M. Mason
  • Patent number: 5700289
    Abstract: Periosteal cells have been grown in cell culture and have been shown to have an osteoblastic phenotype, with production of osteocalcin and glycosaminoglycan. When seeded into polymeric implants, repair of critical size cranial defects was demonstrated and was confirmed by histology, biochemical assays, and radiodensitometry.
    Type: Grant
    Filed: October 20, 1995
    Date of Patent: December 23, 1997
    Assignee: North Shore University Hospital Research Corporation
    Inventors: Arnold S. Breitbart, Daniel A. Grande
  • Patent number: RE46402
    Abstract: Provided are tissue scaffolds colonized by vertebrate cells expressing, a transgenic bioactive molecule, where the vertebrate cells are unable to undergo mitosis. Also provided are methods of growing tissue in a mammal and methods of delivering a transgenic bioactive molecule to a tissue of a mammal, using the tissue scaffolds. Additionally, methods of making the tissue scaffolds are provided.
    Type: Grant
    Filed: January 13, 2016
    Date of Patent: May 16, 2017
    Assignee: The Feinstein Institute for Medical Research
    Inventors: Daniel A. Grande, James M. Mason, Arnold S. Breitbart